Combining a WT1 cancer vaccine (galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1-expressing diffuse pleural mesothelioma (DPM): A phase I study

被引：0
|
作者：
Agrawal, Prashasti [1 ]
Offin, Michael [1 ]
Ginsberg, Michelle S. [1 ]
Adusumilli, Prasad S. [1 ]
Rusch, Valerie W. [1 ]
Sauter, Jennifer L. [1 ]
Ho, Teresa [1 ]
Wong, Phillip [1 ]
Zauderer, Marjorie Glass [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8083
引用
收藏
页数：1
相关论文
共 37 条
  • [1] Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study
    Agrawal, Prashasti
    Offin, Michael
    Lai, Victoria
    Ginsberg, Michelle S.
    Adusumilli, Prasad S.
    Rusch, Valerie W.
    Sauter, Jennifer L.
    Ho, Teresa
    Wong, Phillip
    Zauderer, Marjorie G.
    JTO CLINICAL AND RESEARCH REPORTS, 2025, 6 (01):
  • [2] Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission
    Manning-Geist, Beryl L.
    Gnjatic, Sacha
    Aghajanian, Carol
    Konner, Jason
    Kim, Sarah H.
    Sarasohn, Debra
    Soldan, Krysten
    Tew, William P.
    Sarlis, Nicholas J.
    Zamarin, Dmitriy
    Kravetz, Sara
    Laface, Ilaria
    Rasalan-Ho, Teresa
    Qi, Jingjing
    Wong, Phillip
    Sabbatini, Paul J.
    O'Cearbhaill, Roisin E.
    CANCERS, 2023, 15 (05)
  • [3] Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Maslak, Peter G.
    Dao, Tao
    Bernal, Yvette
    Chanel, Suzanne M.
    Zhang, Rong
    Frattini, Mark
    Rosenblat, Todd
    Jurcic, Joseph G.
    Brentjens, Renier J.
    Arcila, Maria E.
    Rampal, Raajit
    Park, Jae H.
    Douer, Dan
    Katz, Laura
    Sarlis, Nicholas
    Tallman, Martin S.
    Scheinberg, David A.
    BLOOD ADVANCES, 2018, 2 (03) : 224 - 234
  • [4] A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
    Zauderer, Marjorie G.
    Tsao, Anne S.
    Dao, Tao
    Panageas, Katherine
    Lai, W. Victoria
    Rimner, Andreas
    Rusch, Valerie W.
    Adusumilli, Prasad S.
    Ginsberg, Michelle S.
    Gomez, Daniel
    Rice, David
    Mehran, Reza
    Scheinberg, David A.
    Krug, Lee M.
    CLINICAL CANCER RESEARCH, 2017, 23 (24) : 7483 - 7489
  • [5] A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ovarian cancer (OC) in second or third remission.
    O'Cearbhaill, Roisin Eilish
    Gnjatic, Sacha
    Aghajanian, Carol
    Iasonos, Alexia
    Konner, Jason A.
    Losada, Nicolle
    Sarasohn, Debra
    Rasalan, Teresa
    Tew, William P.
    Zamarin, Dmitriy
    Wong, Phillip
    Sabbatini, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome
    Ueda, Yasunori
    Ogura, Michinori
    Miyakoshi, Shigesaburo
    Suzuki, Takahiro
    Heike, Yuji
    Tagashira, Shuzo
    Tsuchiya, Satoru
    Ohyashiki, Kazuma
    Miyazaki, Yasushi
    CANCER SCIENCE, 2017, 108 (12): : 2445 - 2453
  • [7] A Phase 1/2 Study of WT1 Peptide Cancer Vaccine WT4869 in Patients with Myelodysplastic Syndromes (MDS)
    Suzuki, Takahiro
    Ueda, Yasunori
    Ogura, Michinori
    Uchida, Toshiki
    Ozawa, Keiya
    Miyakoshi, Shigesaburo
    Naoe, Tomoki
    Murata, Makoto
    Kizaki, Masahiro
    Uike, Naokuni
    Abe, Yasunobu
    Hidaka, Michihiro
    Tagashira, Shuzo
    Tsuchiya, Satoru
    Ohyashiki, Kazuma
    Miyazaki, Yasushi
    BLOOD, 2015, 126 (23)
  • [8] Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM).
    Krug, L. M.
    Tsao, A. S.
    Kass, S.
    Rusch, V. W.
    Travis, W. D.
    Panageas, K.
    Adusumili, P. S.
    Kris, M. G.
    Maslak, P. G.
    Scheinberg, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+platinum-resistant ovarian cancer in 2nd/3rd line of therapy
    OCearbhaill, Roisin
    Holmes, Jarrod
    Bastos, Bruno
    Fu, Siqing
    Muenzen, Reid
    Cohen, Julia
    Cicic, Dragan
    Ali, Sami
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A199 - A200
  • [10] Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy.
    Zauderer, Marjorie Glass
    Dao, Tao
    Rusch, Valerie W.
    Ginsberg, Michelle S.
    Tsao, Anne S.
    Panageas, Katherine
    Stergiou, Angelos M.
    Scheinberg, David A.
    Krug, Lee M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
1234